ArticlePLoS pathogens2021

Low-dose IL-2 therapy invigorates CD8+ T cells for viral control in systemic lupus erythematosus.

Pengcheng Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.